Hepatitis C Virus (HCV) interaction with astrocytes: Nonproductive infection and induction of IL-18

Journal of NeuroVirology

Volumn 20, Issue 3, 2014, Pages 278-293

  Liu, Ziqing ^a   Zhao, Fang ^a,b   He, Johnny J ^a,c  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b 3rd People s Hospital   (China)

^c UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

Astrocytes; HCV; IL 18; Neurotoxicity; Productive infection; Proinflammatory cytokines

Indexed keywords

INTERLEUKIN 18; VIRUS RECEPTOR; LUCIFERASE; MICRORNA; MIRN122 MICRORNA, HUMAN; VIRUS RNA;

ARTICLE; ASTROCYTE; CENTRAL NERVOUS SYSTEM INFECTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; HEPATITIS C VIRUS; HEPATITIS C VIRUS INFECTION; HUMAN; HUMAN CELL; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RNA TRANSLATION; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS EXPRESSION; VIRUS INFECTION; VIRUS REPLICATION; ASTROCYTOMA; BRAIN; CELL COMMUNICATION; CYTOLOGY; FETUS; GENE EXPRESSION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HEK293 CELL LINE; HEPACIVIRUS; HEPATITIS C; HEPG2 CELL LINE; IMMUNOLOGY; NEUROBLASTOMA; PATHOLOGY; PRIMARY CELL CULTURE; VIROLOGY;

HEPATITIS C VIRUS;

ASTROCYTES; ASTROCYTOMA; BRAIN; CELL COMMUNICATION; FETUS; GENE EXPRESSION; HEK293 CELLS; HEP G2 CELLS; HEPACIVIRUS; HEPATITIS C; HUMANS; INTERLEUKIN-18; LUCIFERASES; MICRORNAS; NEUROBLASTOMA; PRIMARY CELL CULTURE; RECEPTORS, VIRUS; RNA, VIRAL; VIRUS REPLICATION;

EID: 84905369398     PISSN: 13550284     EISSN: 15382443     Source Type: Journal    
DOI: 10.1007/s13365-014-0245-7     Document Type: Article

References (102)

1. Akira S (2000) The role of IL-18 in innate immunity. Curr Opin Immunol 12:59-63
2. Alboni S, Cervia D, Sugama S, Conti B (2010) Interleukin 18 in the CNS. J Neuroinflammation 7:9
3. An P, Thio CL, Kirk GD, Donfield S, Goedert JJ, Winkler CA (2008) Regulatory polymorphisms in the interleukin-18 promoter are associated with hepatitis C virus clearance. J Infect Dis 198:1159-1165
4. Asakawa M, Kono H, Amemiya H, Matsuda M, Suzuki T, Maki A, Fujii H (2006) Role of interleukin-18 and its receptor in hepatocellular carcinoma associated with hepatitis C virus infection. Int J Cancer 118:564-570 (Pubitemid 43076003)
5. Bartosch B, Dubuisson J, Cosset FL (2003) Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes. J Exp Med 197:633-642 (Pubitemid 36314658)
6. Boeuf P, Vigan-Womas I, Jublot D, Loizon S, Barale JC, Akanmori BD, Mercereau-Puijalon O, Behr C (2005) CyProQuant-PCR: a real time RT-PCR technique for profiling human cytokines, based on external RNA standards, readily automatable for clinical use.BMC Immunol 6:5
7. Bouzier-Sore AK, Merle M, Magistretti PJ, Pellerin L (2002) Feeding active neurons: (re)emergence of a nursing role for astrocytes. J Physiol Paris 96:273-282 (Pubitemid 36090365)
8. Bsibsi M, Ravid R, Gveric D, van Noort JM (2002) Broad expression of Toll-like receptors in the human central nervous system. J Neuropathol Exp Neurol 61:1013-1021 (Pubitemid 35278723)
9. Bsibsi M, Persoon-Deen C, Verwer RW, Meeuwsen S, Ravid R, Van Noort JM (2006) Toll-like receptor 3 on adult human astrocytes triggers production of neuroprotective mediators. Glia 53:688-695
10. Carpentier PA, Duncan DS, Miller SD (2008) Glial toll-like receptor signaling in central nervous system infection and autoimmunity. Brain Behav Immun 22:140-147 (Pubitemid 350299811)
11. Carroll-Anzinger D, Al-Harthi L (2006) Gamma interferon primes productive human immunodeficiency virus infection in astrocytes. J Virol 80:541-544
12. Carroll-Anzinger D, Kumar A, Adarichev V, Kashanchi F, Al-Harthi L (2007) Human immunodeficiency virus-restricted replication in astrocytes and the ability of gamma interferon to modulate this restriction are regulated by a downstream effector of the Wnt signaling pathway. J Virol 81:5864-5871 (Pubitemid 46847023)
13. Chakraborty S, Nazmi A, Dutta K, Basu A (2010) Neurons under viral attack: victims or warriors? Neurochem Int 56:727-735
14. Chen Y, Swanson RA (2003) Astrocytes and brain injury. J Cereb Blood Flow Metab 23:137-149 (Pubitemid 36188452)
15. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M (1989) Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244:359-362 (Pubitemid 19117877)
16. Conrad KD, Giering F, Erfurth C, Neumann A, Fehr C, Meister G, Niepmann M (2013) MicroRNA-122 dependent binding of Ago2 protein to hepatitis C virus RNA is associated with enhanced RNA stability and translation stimulation. PLoS One 8:e56272
17. Conti B, Park LC, Calingasan NY, Kim Y, Kim H, Bae Y, Gibson GE, Joh TH (1999) Cultures of astrocytes and microglia express interleukin 18. Brain Res Mol Brain Res 67:46-52 (Pubitemid 29170067)
18. Das S, Mishra MK, Ghosh J, Basu A (2008) Japanese encephalitis virus infection induces IL-18 and IL-1beta in microglia and astrocytes: correlation with in vitro cytokine responsiveness of glial cells and subsequent neuronal death. J Neuroimmunol 195:60-72
19. Dinarello CA (1999) IL-18: a TH1-inducing, proinflammatory cytokine and new member of the IL-1 family. J Allergy Clin Immunol 103:11-24
20. Dreux M, Garaigorta U, Boyd B, Decembre E, Chung J, Whitten-Bauer C, Wieland S, Chisari FV (2012) Short-range exosomal transfer of viral RNA from infected cells to plasmacytoid dendritic cells triggers innate immunity. Cell Host Microbe 12:558-570
21. Evans MJ, von Hahn T, Tscherne DM, Syder AJ, Panis M, Wolk B, Hatziioannou T, McKeating JA, Bieniasz PD, Rice CM (2007) Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature 446:801-805 (Pubitemid 46582027)
22. Fan Y, Zou W, Green LA, Kim BO, He JJ (2011) Activation of Egr-1 expression in astrocytes by HIV-1 Tat: new insights into astrocyte-mediated Tat neurotoxicity. J Neuroimmune Pharm 6:121-129
23. Farina C, Aloisi F, Meinl E (2007) Astrocytes are active players in cerebral innate immunity. Trends Immunol 28:138-145 (Pubitemid 46283692)
24. Fehr C, Conrad KD, Niepmann M (2012) Differential stimulation of hepatitis C virus RNA translation by microRNA-122 in different cell cycle phases. Cell Cycle 11:277-285
25. Felderhoff-Mueser U, Schmidt OI, Oberholzer A, Buhrer C, Stahel PF (2005) IL-18: a key player in neuroinflammation and neurodegeneration? Trends Neurosci 28:487-493 (Pubitemid 41187798)
26. Forton DM, Allsop JM, Main J, Foster GR, Thomas HC, Taylor-Robinson SD (2001) Evidence for a cerebral effect of the hepatitis C virus. Lancet 358:38-39 (Pubitemid 32709741)
27. Forton DM, Thomas HC, Murphy CA, Allsop JM, Foster GR, Main J, Wesnes KA, Taylor-Robinson SD (2002) Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease. Hepatology 35:433-439 (Pubitemid 34106386)
28. Forton DM, Karayiannis P, Mahmud N, Taylor-Robinson SD, Thomas HC (2004) Identification of unique hepatitis C virus quasispecies in the central nervous system and comparative analysis of internal translational efficiency of brain, liver, and serum variants. J Virol 78:5170-5183 (Pubitemid 38581469)
29. Forton DM, Allsop JM, Cox IJ, Hamilton G, Wesnes K, Thomas HC, Taylor-Robinson SD (2005) A review of cognitive impairment and cerebral metabolite abnormalities in patients with hepatitis C infection. AIDS 19(Suppl 3):S53-S63 (Pubitemid 41682170)
30. Foster GR, Goldin RD, Thomas HC (1998) Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis. Hepatology 27:209-212
31. Friedman A, Perrimon N (2006) A functional RNAi screen for regulators of receptor tyrosine kinase and ERK signalling. Nature 444:230-234 (Pubitemid 44722065)
32. Fukuhara T, Kambara H, Shiokawa M, Ono C, Katoh H, Morita E, Okuzaki D, Maehara Y, Koike K, Matsuura Y (2012) Expression of microRNA miR-122 facilitates an efficient replication in nonhepatic cells upon infection with hepatitis C virus. J Virol 86:7918-7933
33. Giulietti A, Overbergh L, Valckx D, Decallonne B, Bouillon R, Mathieu C (2001) An overview of real-time quantitative PCR: applications to quantify cytokine gene expression. Methods 25:386-401 (Pubitemid 34164011)
34. Goergen D, Niepmann M (2012) Stimulation of hepatitis C virus RNA translation by microRNA-122 occurs under different conditions in vivo and in vitro. Virus Res 167:343-352
35. Goh J, Coughlan B, Quinn J, O'Keane JC, Crowe J (1999) Fatigue does not correlate with the degree of hepatitis or the presence of autoimmune disorders in chronic hepatitis C infection. Eur J Gastroenterol Hepatol 11:833-838 (Pubitemid 29389513)
36. Gorry PR, Ong C, Thorpe J, Bannwarth S, Thompson KA, Gatignol A, Vesselingh SL, Purcell DF (2003) Astrocyte infection by HIV-1: mechanisms of restricted virus replication, and role in the pathogenesis of HIV-1-associated dementia. Curr HIV Res 1:463-473
37. Haas SL, Weiss C, Bugert P, Gundt J, Witt H, Singer MV, Berg T, Bocker U (2009) Interleukin 18 promoter variants (-137G>C and -607C> A) in patients with chronic hepatitis C: association with treatment response. J Clin Immunol 29:620-628
38. He J, Chen Y, Farzan M, Choe H, Ohagen A, Gartner S, Busciglio J, Yang X, Hofmann W, Newman W, Mackay CR, Sodroski J, Gabuzda D (1997) CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia. Nature 385:645-649
39. Henke JI, Goergen D, Zheng J, Song Y, Schuttler CG, Fehr C, Junemann C, Niepmann M (2008) microRNA-122 stimulates translation of hepatitis C virus RNA. EMBO J 27:3300-3310
40. Hilsabeck RC, Perry W, Hassanein TI (2002) Neuropsychological impairment in patients with chronic hepatitis C. Hepatology 35:440-446 (Pubitemid 34106387)
41. Hudson CA, Christophi GP, Gruber RC, Wilmore JR, Lawrence DA, Massa PT (2008) Induction of IL-33 expression and activity in central nervous system glia. J Leukoc Biol 84:631-643
42. Jack CS, Arbour N, Manusow J, Montgrain V, Blain M, McCrea E, Shapiro A, Antel JP (2005) TLR signaling tailors innate immune responses in human microglia and astrocytes. J Immunol 175:4320-4330 (Pubitemid 41361966)
43. Janabi N, Di Stefano M, Wallon C, Hery C, Chiodi F, Tardieu M (1998) Induction of human immunodeficiency virus type 1 replication in human glial cells after proinflammatory cytokines stimulation: effect of IFNgamma, IL1beta, and TNFalpha on differentiation and chemokine production in glial cells. Glia 23:304-315 (Pubitemid 28320597)
44. Jangra RK, Yi M, Lemon SM (2010) Regulation of hepatitis C virus translation and infectious virus production by the microRNA miR-122. J Virol 84:6615-6625
45. Jopling CL, Yi M, Lancaster AM, Lemon SM, Sarnow P (2005) Modulation of hepatitis C virus RNA abundance by a liver-specific microRNA. Science 309:1577-1581 (Pubitemid 41266486)
46. Kambara H, Fukuhara T, Shiokawa M, Ono C, Ohara Y, Kamitani W, Matsuura Y (2012) Establishment of a novel permissive cell line for the propagation of hepatitis C virus by expression of microRNA miR122. J Virol 86:1382-1393
47. Komurian-Pradel F, Perret M, Deiman B, Sodoyer M, Lotteau V, Paranhos-Baccala G, Andre P (2004) Strand specific quantitative real-time PCR to study replication of hepatitis C virus genome. J Virol Methods 116:103-106 (Pubitemid 38056658)
48. Kramer L, Bauer E, Funk G, Hofer H, Jessner W, Steindl-Munda P, Wrba F, Madl C, Gangl A, Ferenci P (2002) Subclinical impairment of brain function in chronic hepatitis C infection. J Hepatol 37:349-354 (Pubitemid 34969951)
49. Kruger S, Brandt E, Klinger M, Kreft B (2000) Interleukin-8 secretion of cortical tubular epithelial cells is directed to the basolateral environment and is not enhanced by apical exposure to Escherichia coli. Infect Immun 68:328-334 (Pubitemid 30016714)
50. LaPensee CR, Hugo ER, Ben-Jonathan N (2008) Insulin stimulates interleukin-6 expression and release in LS14 human adipocytes through multiple signaling pathways. Endocrinology 149:5415-5422
51. Laskus T, Radkowski M, Bednarska A, Wilkinson J, Adair D, Nowicki M, Nikolopoulou GB, Vargas H, Rakela J (2002) Detection and analysis of hepatitis C virus sequences in cerebrospinal fluid. J Virol 76:10064-10068 (Pubitemid 35006549)
52. Laskus T, Radkowski M, Adair DM, Wilkinson J, Scheck AC, Rakela J (2005) Emerging evidence of hepatitis C virus neuroinvasion. AIDS 19(Suppl 3):S140-S144 (Pubitemid 41682182)
53. Lee SC, Liu W, Brosnan CF, Dickson DW (1992) Characterization of primary human fetal dissociated central nervous system cultures with an emphasis on microglia. Lab Invest 67:465-476
54. Lee SC, Hatch WC, Liu W, Kress Y, Lyman WD, Dickson DW (1993) Productive infection of human fetal microglia by HIV-1. Am J Pathol 143:1032-1039 (Pubitemid 24070544)
55. Lee LY, Tong CY, Wong T, Wilkinson M (2012) New therapies for chronic hepatitis C infection: a systematic review of evidence from clinical trials. Int J Clin Pract 66:342-355
56. Letendre S, Paulino Amy D, Rockenstein E, Adame A, Crews L, Cherner M, Heaton R, Ellis R, Everall Ian P, Grant I, Masliah E (2007) Pathogenesis of hepatitis C virus coinfection in the brains of patients infected with HIV. J Inf Dis 196:361-370 (Pubitemid 47093886)
57. Li W, Henderson LJ, Major EO, Al-Harthi L (2011) IFN-gamma mediates enhancement of HIV replication in astrocytes by inducing an antagonist of the beta-catenin pathway (DKK1) in a STAT 3-dependent manner. J Immunol 186:6771-6778
58. Li Y, Masaki T, Yamane D, McGivern DR, Lemon SM (2013) Competing and noncompeting activities of miR-122 and the 5′ exonuclease Xrn1 in regulation of hepatitis C virus replication. Proc Natl Acad Sci U S A 110:1881-1886
59. Liu Z, He JJ (2013) Cell - cell contact-mediated hepatitis C virus (HCV) transfer, productive infection, and replication and their requirement for HCV receptors. J Virol 87:8545-8558
60. Liu Y, Liu H, Kim BO, Gattone VH, Li J, Nath A, Blum J, He JJ (2004) CD4-independent infection of astrocytes by human immunodeficiency virus type 1: requirement for the human mannose receptor. J Virol 78:4120-4133 (Pubitemid 38437218)
61. Liu J, Henao-Mejia J, Liu H, Zhao Y, He JJ (2011) Translational regulation of HIV-1 replication by HIV-1 Rev cellular cofactors Sam68, eIF5A, hRIP, and DDX3. J Neuroimmune Pharm 6:308-321
62. Manohar K, Suneetha PV, Sukriti, Pati NT, Gupta AC, Hissar S, Sakhuja P, Sarin SK (2009) Association of IL-18 promoter polymorphism with liver disease severity in HCV-infected patients. Hepatol Int 3:371-377
63. Marukian S, Jones CT, Andrus L, Evans MJ, Ritola KD, Charles ED, Rice CM, Dustin LB (2008) Cell culture-produced hepatitis C virus does not infect peripheral blood mononuclear cells. Hepatology 48:1843-1850
64. Megias L, Guerri C, Fornas E, Azorin I, Bendala E, Sancho-Tello M, Duran JM, Tomas M, Gomez-Lechon MJ, Renau-Piqueras J (2000) Endocytosis and transcytosis in growing astrocytes in primary culture. Possible implications in neural development. Int J Dev Biol 44:209-221 (Pubitemid 30190757)
65. Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST (2013) Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology 57:1333-1342
66. Mohran ZY, Ali-Eldin FA, Abdel Aal HA (2011) Serum interleukin-18: does it have a role in the diagnosis of hepatitis C virus related hepatocellular carcinoma? Arab J Gastroenterol 12:29-33
67. Narbus CM, Israelow B, Sourisseau M, Michta ML, Hopcraft SE, Zeiner GM, Evans MJ (2011) HepG2 cells expressing microRNA miR-122 support the entire hepatitis C virus life cycle. J Virol 85:12087-12093
68. Ousman SS, Kubes P (2012) Immune surveillance in the central nervous system. Nat Neurosci 15:1096-1101
69. Paulino AD, Ubhi K, Rockenstein E, Adame A, Crews L, Letendre S, Ellis R, Everall IP, Grant I, Masliah E (2011) Neurotoxic effects of the HCV core protein are mediated by sustained activation of ERK via TLR2 signaling. J Neurovirol 17:327-340
70. Peterson PK, Gekker G, Hu S, Lokensgard J, Portoghese PS, Chao CC (1999) Endomorphin-1 potentiates HIV-1 expression in human brain cell cultures: implication of an atypical mu-opioid receptor. Neuropharmacology 38:273-278 (Pubitemid 29073547)
71. Pham TNQ, MacParland SA, Mulrooney PM, Cooksley H, Naoumov NV, Michalak TI (2004) Hepatitis C virus persistence after spontaneous or treatment-induced resolution of hepatitis C. J Virol 78:5867-5874 (Pubitemid 38661674)
72. Pien GC, Satoskar AR, Takeda K, Akira S, Biron CA (2000) Cutting edge: selective IL-18 requirements for induction of compartmental IFN-gamma responses during viral infection. J Immunol 165:4787-4791
73. Pileri P, Uematsu Y, Campagnoli S, Galli G, Falugi F, Petracca R, Weiner AJ, Houghton M, Rosa D, Grandi G, Abrignani S (1998) Binding of hepatitis C virus to CD81. Science 282:938-941 (Pubitemid 28507525)
74. Pirhonen J (2001) Regulation of IL-18 expression in virus infection. Scand J Immunol 53:533-539
75. Ploss A, Evans MJ, Gaysinskaya VA, Panis M, You H, de Jong YP, Rice CM (2009) Human occludin is a hepatitis C virus entry factor required for infection of mouse cells. Nature 457:882-886
76. Poynard T, Bedossa P, Opolon P (1997) Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 349:825-832 (Pubitemid 27129209)
77. Radkowski M, Wilkinson J, Nowicki M, Adair D, Vargas H, Ingui C, Rakela J, Laskus T (2002) Search for hepatitis C virus negativestrand RNA sequences and analysis of viral sequences in the central nervous system: evidence of replication. J Virol 76:600-608 (Pubitemid 34033359)
78. Radkowski M, Bednarska A, Horban A, Stanczak J, Wilkinson J, Adair DM, Nowicki M, Rakela J, Laskus T (2004) Infection of primary human macrophages with hepatitis C virus in vitro: induction of tumour necrosis factor-alpha and interleukin 8. J Gen Virol 85:47-59 (Pubitemid 38128869)
79. Radkowski M, Gallegos-Orozco JF, Jablonska J, Colby TV, Walewska-Zielecka B, Kubicka J, Wilkinson J, Adair D, Rakela J, Laskus T (2005) Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C. Hepatology 41:106-114 (Pubitemid 40066388)
80. Ransohoff RM, Brown MA (2012) Innate immunity in the central nervous system. J Clin Invest 122:1164-1171
81. Roessmann U, Gambetti P (1986) Astrocytes in the developing human brain. An immunohistochemical study. Acta Neuropathol 70:308-313 (Pubitemid 16046834)
82. Sareneva T, Matikainen S, Kurimoto M, Julkunen I (1998) Influenza A virus-induced IFN-alpha/beta and IL-18 synergistically enhance IFN-gamma gene expression in human T cells. J Immunol 160:6032-6038 (Pubitemid 28298066)
83. Sarhan MA, Pham TN, Chen AY, Michalak TI (2012) Hepatitis C virus infection of human T lymphocytes is mediated by CD5. J Virol 86:3723-3735
84. Scarselli E, Ansuini H, Cerino R, Roccasecca RM, Acali S, Filocamo G, Traboni C, Nicosia A, Cortese R, Vitelli A (2002) The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus. EMBO J 21:5017-5025
85. Sharma SD (2010) Hepatitis C virus: molecular biology & current therapeutic options. Indian J Med Res 131:17-34
86. Sharma A, Chakraborti A, Das A, Dhiman RK, Chawla Y (2009) Elevation of interleukin-18 in chronic hepatitis C: implications for hepatitis C virus pathogenesis. Immunology 128:e514-e522
87. Sherker AH, Twu JS, Reyes GR, Robinson WS (1993) Presence of viral replicative intermediates in the liver and serum of patients infected with hepatitis C virus. J Med Virol 39:91-96 (Pubitemid 23062355)
88. Shimakami T, Yamane D, Jangra RK, Kempf BJ, Spaniel C, Barton DJ, Lemon SM (2012) Stabilization of hepatitis C virus RNA by an Ago2-miR-122 complex. Proc Natl Acad Sci U S A 109:941-946
89. Shrivastava S, Mukherjee A, Ray R, Ray RB (2013) Hepatitis C virus induces interleukin-1beta (IL-1beta)/IL-18 in circulatory and resident liver macrophages. J Virol 87:12284-12290
90. Suk K, Yeou Kim S, Kim H (2001) Regulation of IL-18 production by IFN gamma and PGE2 in mouse microglial cells: involvement of NF-kB pathway in the regulatory processes. Immunol Lett 77:79-85 (Pubitemid 32480123)
91. Takeuchi T, Katsume A, Tanaka T, Abe A, Inoue K, Tsukiyama-Kohara K, Kawaguchi R, Tanaka S, Kohara M (1999) Real-time detection system for quantification of hepatitis C virus genome. Gastroenterology 116:636-642 (Pubitemid 29106771)
92. Tang H, Grisé H (2009) Cellular and molecular biology of HCVinfection and hepatitis. Clin Sci 117:49-65
93. Timpe JM, Stamataki Z, Jennings A, Hu K, Farquhar MJ, Harris HJ, Schwarz A, Desombere I, Roels GL, Balfe P, McKeating JA (2008) Hepatitis C virus cell - cell transmission in hepatoma cells in the presence of neutralizing antibodies. Hepatology 47:17-24 (Pubitemid 351171037)
94. van de Veerdonk FL, Netea MG, Dinarello CA, Joosten LA (2011) Inflammasome activation and IL-1beta and IL-18 processing during infection. Trends Immunol 32:110-116
95. Vargas HE, Laskus T, Radkowski M, Wilkinson J, Balan V, Douglas DD, Harrison ME, Mulligan DC, Olden K, Adair D, Rakela J (2002) Detection of hepatitis C virus sequences in brain tissue obtained in recurrent hepatitis C after liver transplantation. Liver Transpl 8:1014-1019 (Pubitemid 35363627)
96. Vivithanaporn P, Maingat F, Lin LT, Na H, Richardson CD, Agrawal B, Cohen EA, Jhamandas JH, Power C (2010) Hepatitis C virus core protein induces neuroimmune activation and potentiates human immunodeficiency virus-1 neurotoxicity. PLoS One 5:e12856
97. Vlassov AV, Magdaleno S, Setterquist R, Conrad R (2012) Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials. Biochim Biophys Acta 1820:940-948
98. Weissenborn K, Krause J, Bokemeyer M, Hecker H, Schuler A, Ennen JC, Ahl B, Manns MP, Boker KW (2004) Hepatitis C virus infection affects the brain-evidence from psychometric studies and magnetic resonance spectroscopy. J Hepatol 41:845-851 (Pubitemid 39434316)
99. Wilkinson J, Radkowski M, Laskus T (2008) Hepatitis C virus neuroinvasion: identification of infected cells. J Virol 83:1312-1319
100. Wilkinson J, Radkowski M, Eschbacher JM, Laskus T (2010) Activation of brain macrophages/microglia cells in hepatitis C infection. Gut 59(10):1394-1400
101. Xing Z, Zganiacz A, Wang J, Divangahi M, Nawaz F (2000) IL-12-independent Th1-type immune responses to respiratory viral infection: requirement of IL-18 for IFN-gamma release in the lung but not for the differentiation of viral-reactive Th1-type lymphocytes. J Immunol 164:2575-2584 (Pubitemid 30115488)
102. Ye L, Wang X, Wang S, Luo G, Wang Y, Liang H, Ho W (2008) Centrifugal enhancement of hepatitis C virus infection of human hepatocytes. J Virol Methods 148:161-165